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Abstract
Globally, epilepsy is a common serious brain disorder. In addition to seizure activity, epi-
lepsy is associated with cognitive impairments including static cognitive impairments pres-
ent at onset, progressive seizure-induced impairments and co-morbid dementia. Epilepsy
occurs naturally in domestic dogs but its impact on canine cognition has yet to be studied,
despite canine cognitive dysfunction (CCD) recognised as a spontaneous model of de-
mentia. Here we use data from a psychometrically validated tool, the canine cognitive dys-
function rating (CCDR) scale, to compare cognitive dysfunction in dogs diagnosed with
idiopathic epilepsy (IE) with controls while accounting for age. An online cross-sectional
study resulted in a sample of 4051 dogs, of which n = 286 had been diagnosed with IE. Four
factors were significantly associated with a diagnosis of CCD (above the diagnostic cut-off
of CCDR50): (i) epilepsy diagnosis: dogs with epilepsy were at higher risk; (ii) age: older
dogs were at higher risk; (iii) weight: lighter dogs (kg) were at higher risk; (iv) training history:
dogs with more exposure to training activities were at lower risk. Impairments in memory
were most common in dogs with IE, but progression of impairments was not observed com-
pared to controls. A significant interaction between epilepsy and age was identified, with
IE dogs exhibiting a higher risk of CCD at a young age, while control dogs followed the
expected pattern of low-risk throughout middle age, with risk increasing exponentially in
geriatric years. Within the IE sub-population, dogs with a history of cluster seizures and high
seizure frequency had higher CCDR scores. The age of onset, nature and progression of
cognitive impairment in the current IE dogs appear divergent from those classically seen in
CCD. Longitudinal monitoring of cognitive function from seizure onset is required to further
characterise these impairments.
Introduction
In human neurology it is widely recognised that epilepsy is associated with cognitive
impairment, with impaired cognition considered so prevalent that there are calls for repeated
cognitive screening for all epilepsy patients [1]. Cognitive impairments in epilepsy vary in
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severity, onset and progression. Impairments range from mild learning difficulties through to
severe mental decline [2] and may be static or progressive, transient or permanent. Indeed,
cognitive profiles in epilepsy are considered to be as heterogeneous as the epileptic syndromes
themselves [3]. The cause of epilepsy and the neuropathology associated with it often dictate
the expression of cognitive comorbidities [4]. Greater severity of cognitive impairment is seen
in symptomatic/structural epilepsies (where seizures are a symptom of an underlying problem,
such as stroke, trauma, infection, congenital brain malformation, tumours, or metabolic disor-
ders [5]), than in idiopathic epilepsy (IE) [6], where epilepsy is the direct result of a presump-
tive but unknown genetic defect(s) [5]. Even still, cognitive dysfunction is common in IE, a
cluster of syndromes that represents approximately 20% of all epilepsies [7].
There is debate as to whether cognitive impairments in epilepsy are (i) progressive, and as a
result of the recurrent seizure activity that characterises epilepsy, (ii) static, and present from
the onset of epilepsy, or (iii) due to other co-morbid neurological diseases. Part of this early
debate was further complicated by studies suggesting a slow cognitive decline with increased
duration of epilepsy, but epilepsy duration is heavily confounded by ageing that is itself associ-
ated with cognitive decline. It is possible that the nature and progression of decline varies
between individuals with epilepsy, and multiple processes that compromise cognition may
occur contemporaneously.
Epilepsy is characterised by recurrent seizure activity, and in some epilepsy syndromes, evi-
dence suggests that recurrent seizure activity has a role in cognitive decline. A review of twenty
longitudinal studies that examined cognitive outcomes in patients with epilepsy concluded
that there is a ‘mild but definite’ relationship between seizures and mental decline [8]. Seizures
in the human temporal lobe (TLE) transiently impair cognition and steadily damage hippo-
campal circuitry, leading to progressive memory loss [9]. Patients with a longer duration of
TLE have a lower IQ than those with a shorter duration [10] and, in a longitudinal study of
TLE patients, progressive decline in cognition preferentially occurred in patients with ongoing
seizures. In contrast, patients who became seizure-free after resection of the dysfunctional hip-
pocampal structures improved or recovered from their previous deficits [11].
Other studies suggest that cognitive deficits in chronic epilepsy cannot be interpreted exclu-
sively as long-term effects of recurrent seizure activity, and that these early deficits are better cat-
egorised as initial symptoms of epilepsy, the severity of which may then increase in the long-
term course of the disease or take the course of physiological ageing [3]. Indeed, approximately
half of newly diagnosed children or adults with epilepsy have demonstrable cognitive or beha-
vioural difficulties on testing [12–14]. Contrary to previous assumptions, age regressions for
healthy controls and patients with TLE appear to run in parallel, with TLE patients performing
worse than controls, while the distance between groups remained stable over time [15]. This
may indicate that the cognitive problems in epilepsy evolves around the time of epilepsy onset
or perhaps even earlier. It is possible that epilepsy interferes with the developmental trajectory
of brain networks underlying cognition [16], and that the underlying aetiology of epilepsy is
involved in the mechanism of permanent cognitive deficits [17]. Even where the rate of cogni-
tive decline in epilepsy is slow, patients who start at a lower baseline cognitive level than healthy
individuals may reach a clinically significant threshold of impairment earlier in life [15].
Finally, it is possible that cognitive declines in adult and elderly patients with epilepsy are
not solely a consequence of the seizure disorder. Evidence of co-morbidity between epilepsy
and dementia is mounting. Two population-based investigations of medical comorbidities
demonstrated a significantly higher rate of dementia and Alzheimer’s disease (AD) in patients
with epilepsy compared with controls. [18, 19]. In the EURODEM project, eight case–control
studies were reanalysed and the risk for AD was found to be significantly raised in patients
with established epilepsy (duration >10 years) [20]. A 8-year longitudinal study of 4505
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epilepsy patients aged 50–75 years, compared with age-matched controls with other medical
disorders, revealed an age-accelerated risk of dementia [21]. A parallel relationship has also
been found, with epilepsy also being more likely in dementia and AD patients; indeed, in one
study, the incidence ratio of epilepsy in individuals diagnosed with AD was elevated nearly
87-fold [22]. This may indicate a bidirectional relationship between the disorders, such that
dementia may precede or follow the development of epilepsy [20].
Given these disease patterns in humans it is interesting that idiopathic epilepsy is the most
common chronic neurological condition in domestic dogs, with prevalence estimates from
0.6% [23] - 0.75% [24]. Age of onset of IE is most commonly between 6 months and 6 years
[25]. Although there is increasing evidence of neurobehavioural comorbidity in the dog, includ-
ing anxiety and ADHD-like behaviour [26–28], the effect of IE on canine cognition has yet to
be explored. Canine cognitive dysfunction (CCD) or ‘canine dementia’ is a recognised neurobe-
havioural syndrome in aged dogs, characterized by deficits in learning, memory and spatial
awareness, as well as changes to social interactions and sleeping patterns [29]. CCD is common
in aged dogs [30–32], but underdiagnosed [33] with a large community-based sample estimat-
ing it affects ~12% of dogs greater than 10 years and doubling in prevalence every 2 years there-
after [34]. In addition, anxiety has been observed in around half of CCD cases, as also seen in
Alzheimer’s disease in humans [35]. With the life expectancy of companion animals increasing
as a consequence of improvements in veterinary care and nutrition, geriatric disorders are
becoming increasingly important in veterinary medicine [36]. Moreover, since both CCD and
IE having the potential to compromise quality of life [34, 37], co-morbidity of these disorders
may have a major negative impact on canine welfare. The primary aim of this study was there-
fore to investigate whether dogs with IE are at higher risk of CCD when accounting for age. If
cognitive impairments were found in the IE population, the secondary aims were:
1. To characterise the age of onset, nature and progression of any cognitive impairment
observed in the population of dogs with IE;
2. To identify disease and treatment-related risk factors for CCD within the population of
dogs with IE; and
Finally, this study aimed to identify other environmental and physical risk factors for CCD
in the overall population.
Methods
Study design and recruitment
A cross-sectional study was conducted using an online survey platform (SurveyMonkey; www.
surveymonkey.co.uk) between June and September 2016, to explore the impact of IE upon
CCD. To avoid response bias associated with revealing the central research question, the sur-
vey was entitled the ‘Mature Dog Study’, with the stated aim being to explore the impact of
canine dogs’ health and training upon their behaviour (See S1 File for full survey). Consent
was gained via a statement in the opening page detailing the storage and use of respondents’
data in accordance with the Data Protection Act 1998. The survey was promoted primarily via
social media, breed clubs and veterinary practices. The study was approved by the local ethics
committee (RVC Animal Welfare and Ethics Committee; approval number 2016/U301).
Subjects
The study aimed to recruit both dogs affected by IE, and controls with no history of recurrent
seizure activity. Dogs were screened for IE by consecutive diagnostic questions, beginning
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with whether they had ever had a seizure (yes/no). Those owners answering no were catego-
rised into the control group. For those answering yes, three further screening questions were
posed: (i) whether their dog had 2 or more seizures that were at least 24 hours apart; (ii)
whether their dog’s first seizure occurred between the ages of 6 months and 6 years; and (iii)
whether their vet had carried out blood and urine tests on their dog and found no identifiable
cause for their dog’s seizures. If the owner answered yes to all three questions, the dog was con-
sidered to meet the tier I diagnostic criteria for the International Veterinary Epilepsy Task
Force (IVETF) [38] and thus was classified as affected. Dogs who had experienced seizure
activity, but whose owners only responded ‘yes’ to one or two of the above screening questions,
were excluded from the study.
CCD is considered a geriatric onset condition, where prevalence increases exponentially
with age. Previous studies have focused on dogs over 8 years of age (e.g. the Senior Dog Survey
[34]); however, this age limit may exclude dogs with early-onset CCD. Therefore, a lower age
limit of 3 years was set as an inclusion criterion for this study, with no upper age limit. set This
allowed for a broader range of dogs that could reveal how cognitive dysfunction may develop
over time in an adult population.
Behavioural data
Cognitive impairment was measured using the canine cognitive dysfunction rating scale
(CCDR), a psychometrically validated tool that quantifies the frequency and progression of
thirteen behaviours which, when abnormal, concur with veterinary diagnoses of canine
dementia almost 80% of the time [34]. The CCDR focuses on problems related to memory
(lack of recognition of owners, house-soiling), orientation (staring blankly, getting lost in the
home), apathy (reduced time spent active, avoiding contact with owners), impaired olfaction
(difficulty finding food) and locomotion. Questions are included in Table 1, with dogs receiv-
ing an overall score out of 80. The diagnostic threshold for canine cognitive dysfunction is set
at a summed CCDR score of50.
To account for the effect of environmental factors upon cognition, a history of previous train-
ing was taken using questions from a recent study of common training activities [39]. For early
life training, owners were asked to report puppy class attendance in the following categories: 0
(never attended), 1–10, 11–20,>20. For adult training, owners were asked to report attendance of
six activities: obedience classes, agility, gundog training, ringcraft, conformational showing and
flyball. For each category, owners responded with their dog’s current or previous attendance and
were allocated a score from 0–2 (0 = No: Never attended, 1 = Yes: Attended but has now stopped,
2 = Yes: Still attends), and an overall adult training score out of 12 was calculated.
Finally, owners were asked to report what training aids and methods they used to train
their dog. Thirteen aids/methods were considered punishment-based (bark-activated citro-
nella collar, prong collar, Pet CorrectorTM, bark collar, water pistol, verbal punishment (e.g.
shouting or telling off), electric collar, choke chain, electronic boundary fence, physical pun-
ishment e.g. smacking when the dog does something wrong, HusherTM, shutting away when
the dog behaves badly, pulling back on the lead when the dog pulls) and five were considered
reward-based (food reward, stroking or patting, verbal praise, playing and clicker training).
Whether the owner used solely punishment-based methods, solely reward-based methods, or
a mix of both methods was recorded.
Clinical data
All owners reported their dog’s breed, sex, neuter status, age (years) and weight (kg). For the
sub-population of dogs with IE, the following additional clinical data were collected: age at
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first seizure, seizure frequency in the past three months, and experience of cluster seizures:
more than one seizure in a 24-hour period; and status epilepticus: a seizure lasting >5 minutes
or two seizures with incomplete recovery of consciousness inter-ictally [38]. Owners were also
asked to report their dog’s current anti-epileptic drug (AED) treatment and historic response
to AEDs.
Statistical analysis
Descriptive statistics were performed in SPSS Statistics v 23 (SPSS, Inc., Chicago) and model-
ling and graphing in R 3.3.3 [40]. Two outcome variables were considered:
1. Overall CCDR score out of 80;
2. CCDR diagnosis as a binary variable based on the optimal diagnostic cut-off (< or50).
We considered the effects on these two outcome variables of the following potential predic-
tors: age (years), sex, neuter status, bodyweight (kg) and idiopathic epilepsy diagnosis. To
determine these variables’ effect upon CCD, linear and binary logistic regression modelling
were used to evaluate potential predictors separately. Results of the univariate analyses were
used to determine which factors to include in the subsequent multivariate models, with those
liberally associated (p<0.2) being carried forward, to ensure that all potentially predictive vari-
ables were studied [41]. Biologically plausible interactions between variables were tested. Gen-
eralised linear models were used to model the effect of IE on CCDR and CCD (1/0). Age
(years) was included as a variable in all models. To improve model fit, polynomials for contin-
uous variables were examined. Model fit was checked by visually inspecting the distribution,
Table 1. Canine cognitive dysfunction rating (CCDR) scale from salvin et al. (2011).
Question (1)
Never
(2)
Once a
month
(3)
Once a
week
(4)
Once a day
(5)
>Once a
day
Score
How often does your dog pace up and down, walk in circles and/or wander with no
direction or purpose?
How often does your dog stare blankly at the walls or floor?
How often does your dog get stuck behind objects and is unable to get around?
How often does your dog fail to recognise familiar people or pets?
How often does your dog walk into walls or doors?
How often does your dog walk away while, or avoid, being patted?
Never 1–30% of
times
31–60% of
times
61–99% of
times
Always Score
How often does your dog have difficulty finding food dropped on the floor?
Much
less
Slightly less The same Slightly
more
Much
more
Score
Compared with 6 months ago, does your dog now pace up and down walk in circles and/
or wander with no direction or purpose
Compared with 6 months ago does your dog now stare blankly at the walls or floor
Compared with 6 months ago does your dog urinate or defecate in an area it has
previously kept clean (if your dog has never house-soiled tick ‘the same’)
Compared with 6 months ago does your dog have difficulty finding food dropped on the
floor
x 2
Compare with 6 months ago does your dog fail to recognise familiar people or pets x 3
Much
more
Slightly
more
The same Slightly less Much less Score
Compared with 6 months ago is the amount of time your dog spends active
https://doi.org/10.1371/journal.pone.0192182.t001
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and the homogeneity of variance, of the residuals, and the Akaike information criterion (AIC)
values of each iteration. The intercept is stated for all multivariate models, the expected mean
value of the response variable (Y) when all predictors (X) equal 0.
Within the IE group, the following predictors of interest were considered for their effect on
CCD: age at first seizure, time since first seizure (epilepsy duration), report of cluster seizures
and/or status epilepticus, current AED treatment, number of AEDs used and historic drug
response. To characterise specific differences in CCD between control and IE cases, differences
in the scores of the thirteen CCDR sub-questions of were compared using linear regression,
controlling for age in all models. All tests were two-sided and P<0.05 was considered to be
significant. Data are presented as mean ± standard deviation (SD), or median (25th-75th quar-
tile), where appropriate.
Results
Study population
Responses were received from the owners of 4710 dogs, of which 4051 were eligible for inclu-
sion. The remainder were excluded due to a history of seizures without meeting diagnostic cri-
teria for a Tier I level diagnosis, or due to being incomplete. Almost three quarters of the sample
were purebred (71.4%), over half of which were registered with a kennel club in their country
(66.7%, n = 1923). There were 173 different breeds represented, the top three being the Border
Collie (9.2%, n = 371), Cavalier King Charles Spaniel (6.5%, n = 265) and Labrador Retriever
(6.1%, n = 248). Most dogs in the sample were neutered, with 42.1% (n = 1707) being neutered
females and 38.3% (n = 1553) being neutered males, 12.2% (n = 494) being entire males, and
7.3% (n = 297) being entire females. The median age of the overall population was 8.17 years
(5.58–10.75), and the median age of the control population was 8.30 years (5.75–10.92).
A total of 286 dogs met the minimum three criteria required for IVETF tier I diagnostic cer-
tainty for IE. Of those dogs meeting tier I, 17% also achieved a atier II certainty diagnosis, as
they had unremarkable fasting and post-prandial bile acids, magnetic resonance imaging of
the brain and cerebrospinal fluid analysis [38]. Dogs with IE (n = 286) were significantly youn-
ger and heavier than controls (p<0.001). Dogs with IE were more likely to be male and neu-
tered than controls (p<0.001). Dogs with IE had a significantly lower adult training score
(epilepsy: 0 (0–1); control: 1 (0–2), p<0.001), but there was no difference in the training
method used (% reward only: IE: 31.4%, control: 29.3%, p = 0.450).
Prevalence of cognitive dysfunction
Using the CCDR diagnostic cut-off value of50, 63 dogs (1.6%) in the overall population,
were considered CCD + and 3988 (98.4%) CCD-. CCD was most common in the oldest age
group (>14 years; 14.2%). In the epilepsy group, the majority of CCD+ cases were aged 4.1–
6.0 years old (Table 2).
Risk factors for CCD
Relevant signalment, disease and environmental variables were screened for their association
with CCD at the univariate level. Five variables were found to differ between the CCD + and
CCD–groups in univariate analyses. Compared with CCD- dogs, those classified as CCD
+ were found to be significantly older, more likely to have epilepsy, be male, lighter, and have
encountered fewer training activities (Table 3).
Variables liberally associated with CCD at the univariate level were taken forward into
binary logistic regression modelling. In the final multivariate model, four variables remained
Cognitive dysfunction in naturally occurring canine idiopathic epilepsy
PLOS ONE | https://doi.org/10.1371/journal.pone.0192182 February 8, 2018 6 / 20
significant: age, IE, bodyweight and training history (Table 4), with a significant interaction
between age and IE diagnosis. The risk of CCD in healthy dogs increased exponentially with
age beyond 10 years; however, risk of CCD in dogs with epilepsy was elevated at a compara-
tively young age (< 4 years) (Fig 1). When controlling for age, light dogs were at an elevated
risk of CCD than heavier dogs (Fig 2).
Risk of cognitive dysfunction in dogs under 8 years
In the study population aged>96 months (8 years), dogs with IE were underrepresented rela-
tive to the population aged96 months, possibly due to the significantly reduced lifespan
associated with epilepsy in dogs (96 months: 10.78% IE cases (215/1996); >96 months:
3.46% IE cases (71/2055)). To refine the association between epilepsy and CCD in the middle-
aged canine population, binary logistic regression models were repeated including only dogs
96 months. Two effects remained significant: IE and the interaction beween IE and age
(Table 5). In this model, age (years), weight (kg) and training history were no longer signifi-
cant predictors of CCD diagnosis in this age range; however, age was retained in the final
model due to its inclusion in a significant interaction term with IE.
In this sub-population, dogs with epilepsy were at a significantly elevated risk of CCD than
controls until around 7 years of age. The risk of CCD in controls remained extremely low
(probability <0.05) for the entire age range (Fig 3).
CCDR score
The CCDR is a continuous score from 16–80. To model risk factors associated with an elevated
CCDR score rather than for CCD+/- as a binary trait, linear regression modelling was used.
Table 2. Prevalence of CCD across different age groups, stratified by clinical group.
Age category Overall (n = 4051) Epilepsy only (n = 286) Control only (n = 3765)
N CCD + CCD - N CCD + CCD - N CCD + CCD -
<4.0 years 439 0.5% 99.5% 48 4.2% 95.8% 391 0.0% 100.0%
4.1–6.0years 752 1.1% 98.9% 91 6.6% 93.4% 661 0.3% 99.7%
6.1–8.0years 805 0.7% 99.3% 76 2.6% 97.4% 729 0.5% 99.5%
8.1–10.0 years 809 0.1% 99.9% 44 0.0% 100.0% 765 0.1% 99.9%
10.1–12.0 years 607 1.0% 99.0% 19 5.3% 94.7% 588 0.9% 99.1%
12.1–14.0 years 428 2.3% 97.7% 6 0.0% 100.0% 422 2.4% 97.6%
>14.0 years 211 14.2% 85.8% 2 0.0% 100.0% 209 14.4% 85.6%
https://doi.org/10.1371/journal.pone.0192182.t002
Table 3. Univariate associations between the presence of CCD (CCDR50) and signalment, clinical and lifestyle variables.
Variable Category CCD - CCD + OR 95% CI p
Age (years) Continuous - - 1.41 1.26–1.57 <0.001
Bodyweight (kg) Continuous - - 0.95 0.92–0.97 <0.001
Sex Female 98.9% 1.1% 0.58 0.35–0.98 0.040
Male 98.0% 2.0% 1 (base)
Neuter status Neutered 98.3% 1.7% 0.51 0.23–1.13 0.095
Entire 99.1% 0.9% 1 (base)
Idiopathic epilepsy Affected 92.6% 3.8% 2.86 1.47–5.54 0.002
Control 98.6% 1.4% 1 (base)
Training method Mixed 98.4% 1.6% -0.138 0.87–1.98 0.622
Reward-only 98.6% 1.4% 1 (base)
Training history Continuous - - 0.38 0.23–0.53 <0.001
https://doi.org/10.1371/journal.pone.0192182.t003
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When CCDR was modelled as a continuous variable all variables from the binary model
remained significant, with the exception of training history (p>0.05). In addition, age was sig-
nificant when fitted as a third degree polynomial, which improved model fit compared to first
or first and second degree polynomials alone (Table 6).
In adult dogs <8 years, dogs with IE had significantly higher CCDR scores which steadily
declined with age, before increasing in the geriatric period. In contrast, control dogs CCDR
scores remained relatively steady until ~10 years, after which CCDR scores increased exponen-
tially (Fig 4).
Nature of cognitive impairment
Eleven of the thirteen median scores for the subcomponents of the CCDR scale significantly
differed between epilepsy and control dogs. Of the seven ‘static’ “how often does your dog”
questions, 6/7 scores were significantly higher (i.e. abnormalities were seen more frequently)
in the IE group (Table 7). Of the six ‘progression’ questions, where current behaviour was
compared to six months previously, 5/6 differed between groups. Time spent active compared
Table 4. Multivariate model of risk factors for CCD in a population of 4051 dogs.
Variable Sub-category Coefficient SE Z p
Intercept - -0.44 1.14 -0.38 0.702
Age (years) - -0.27 0.19 1.46 0.144
Idiopathic epilepsy Affected 8.47 1.35 6.27 <0.001
Control Reference
Bodyweight (kg) - -0.04 0.02 -2.81 0.005
Training history - -0.26 0.13 -2.00 0.045
Age (years)  Idiopathic epilepsy - 0.77 0.20 -3.96 <0.001
N.B. “” indicates an interaction term between two variables
https://doi.org/10.1371/journal.pone.0192182.t004
Fig 1. Probability of being affected by canine cognitive dysfunction (CCD) by age in dogs with epilepsy (n = 286)
and controls (n = 3765). Results based on a generalised linear model with CCD as the binary outcome variable.
https://doi.org/10.1371/journal.pone.0192182.g001
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to six months ago was significantly less in dogs with IE than controls. However, four progres-
sion scores were significantly higher in the control group; how often they stared blankly at the
walls or floor, how often the dog was reported to urinate or defecate in an area it has previously
kept clean, how often the dog had difficulty finding food dropped on the floor, and how often
they failed to recognise familiar people or pets.
Epilepsy sub-population
The mean CCDR score for dogs with IE was 35.05 ± 8.83, with 11 of the 286 dogs CCD+
(3.8%) having reached the threshold score for diagnosis of CCDR50. Of the 286 dogs meet-
ing the criteria for IE diagnosis, the majority (70.3%) were purebred, with the most common
breeds being the Border Collie (n = 34, 11.9%) and Labrador Retriever (n = 16, 5.6%). The
median age was 6.12 years (4.65–8.04) and weight was 22.0 kg (14.0–34.0). Nearly two-thirds
of dogs were male (n = 187, 65.4%) and most were neutered (n = 248, 86.7%). There was no
effect of any of these variables on CCDR score (p>0.05). The median age at first seizure was
32.0 months (18.0–48.50), with the median duration of epilepsy being 33.0 months (19.0–
56.0). Most dogs (75.5%, n = 216) had experienced cluster seizures, and 40.9% (n = 117) were
Fig 2. Probability of being affected by canine cognitive dysfunction (CCD) across weight (kg) in the control
population. N.B. Age is kept constant (8 years old) to examine the effect of weight in isolation.
https://doi.org/10.1371/journal.pone.0192182.g002
Table 5. Multivariate model of risk factors for CCD in dogs96 months of age (n = 1996 dogs).
Variable Sub-category Coefficient SE z p
Intercept - -1.93 1.30 -1.49 0.137
Age (years) - -0.21 0.25 -0.84 0.399
Idiopathic epilepsy Affected 7.57 2.68 2.83 0.005
Control Reference
Age (years)  Idiopathic epilepsy - 0.83 0.42 -1.95 0.050
N.B. “” indicates an interaction term between two variables
https://doi.org/10.1371/journal.pone.0192182.t005
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reported by owners to have entered status epilepticus. The median number of seizures/month
(calculated over the preceding three months) was 1.0 (0.0–1.67). Reports of cluster seizures,
status epilepticus and higher seizure frequency were associated with a higher CCDR score
(Table 8).
Anti-epileptic drugs
Nearly all IE dogs were receiving anti-epileptic medication at the time of reporting (88.8%,
n = 254). The most common AEDs used were phenobarbital (63.3%, n = 181), followed by
potassium bromide (KBr: 30.4%, n = 87), levetiracetam (LEV: 25.9%, n = 74), imepitoin (IMP:
15.7%, n = 45) and zonisamide (ZNS: 10.8%, n = 31). Dogs treated with LEV had a significantly
higher CCDR score than those not treated with this AED, but there were no effects of other
AEDs use, or of the number of AEDs used (Table 8). One fifth of dogs had been seizure-free
since the commencement of their most recent AED regime (19.8%, n = 53). Nearly one quarter
of dogs had had no change in seizure frequency (23.6%, n = 57), while 8.7% (n = 21) had had
Fig 3. Probability of being affected by canine cognitive dysfunction (CCD) by age in dogs with epilepsy (n = 286)
and controls (n = 3765). Data are based on a generalised linear model with CCD as the binary outcome variable.
https://doi.org/10.1371/journal.pone.0192182.g003
Table 6. Generalised linear model of risk factors for CCDR score in a population of 4051 dogs.
Variable Sub-category Estimate SE t p
Intercept - 36.17 1.71 22.48 <0.001
Age (years) Continuous 0.74 0.49 1.50 0.133
Age (years) ^ 2 (quadratic) Continuous -0.18 0.05 -3.39 <0.001
Age (years) ^ 3 (cubic) Continuous 0.01 0.01 4.78 <0.001
Idiopathic epilepsy Affected 4.497 1.095 4.11 <0.001
Control Reference
Bodyweight (kg) Continuous -0.02 0.01 -2.39 0.017
Age (years)  Idiopathic epilepsy Continuous 0.47 0.16 2.98 0.003
N.B.  represents an interaction between two variables
https://doi.org/10.1371/journal.pone.0192182.t006
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an increase in seizure frequency. Dogs who had undergone an increase in seizure frequency
following their most recent AED regime implementation had higher CCDR scores than sei-
zure-free dogs (Table 9).
In a multivariate analysis, two factors significantly predicted CCDR score (Table 10); higher
seizure frequency (quadratic) and history of cluster seizures.
Discussion
This study is the first to explore the interplay between epilepsy and cognitive dysfunction in
the domestic dog, and is the largest epidemiological study of canine cognitive brain ageing to
date. The tool used to quantify cognitive dysfunction in this study, the CCDR, is psychometri-
cally validated and focuses on multiple areas of cognition that are compromised in CCD, and
resemble many of the different stages of human dementia [34]. A significantly increased risk
of CCD was observed in dogs with IE compared to control dogs. However, based on the cur-
rent data, it appears likely that epilepsy-associated cognitive dysfunction represents a different
form of cognitive impairment than the classic ‘canine dementia’ of CCD. This finding is based
on several factors including the (i) nature, (ii) progression and (iii) age of onset of the
impairment, which will now be discussed.
Nature and progression of cognitive impairment in canine epilepsy
When considering specific areas of cognitive compromise captured by the CCDR, dogs with
IE showed significantly greater impairment in six of the seven ‘static’ elements, which chiefly
reflect impairment in memory. These elements include reduced of recognition of owners, and
impairment in spatial memory/orientation, including staring blankly, getting lost in the home,
and having difficulty finding food. Compromised memory is common in people with epilepsy,
and is often seen early in the course of epilepsy, including childhood epilepsies. In a review of
88 studies of memory in children with epilepsy, 78% of the studies reviewed reported that chil-
dren with epilepsy scored lower than controls and normative scores on measures of memory
Fig 4. Effect of idiopathic epilepsy on CCDR score across age (years) in dogs with idiopathic epilepsy (n = 286)
and controls (n = 3765).
https://doi.org/10.1371/journal.pone.0192182.g004
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[42]. The severity of memory impairments in people with epilepsy may be comparable to
patients with precursors to AD [43], and thus the use of the CCDR may lead to false positives
in dogs with epilepsy. In contrast to memory function, dogs with IE did not appear to show
impairment in social interaction, rarely walking away while, or avoiding, being patted, with no
Table 7. Differences in the 13 sub-questions of the canine cognitive dysfunction rating (CCDR) scale between dogs with epilepsy (IE) and controls (C).
Static question Factor Group Score Linear regression
Mean SD B
(IE)
P (IE) B
(Age)
P
(Age)
How often does your dog? Pace up and down, walk in circles and/or wander with no
direction or purpose?
IE 1.85 1.29 0.61 <0.001 0.04 <0.001
C 1.31 0.93
Stare blankly at the walls or floor? IE 1.62 1.13 0.48 <0.001 0.04 <0.001
C 1.20 0.72
Get stuck behind objects and is unable to get around? IE 1.33 0.87 0.27 <0.001 0.02 <0.001
C 1.10 0.49
Fail to recognise familiar people or pets? IE 1.17 0.56 0.13 <0.001 0.01 <0.001
C 1.07 0.40
Walk into walls or doors? IE 1.47 0.97 0.41 <0.001 0.02 <0.001
C 1.10 0.48
Walk away while, or avoid, being patted? IE 1.47 1.01 0.05 0.426 -0.01 0.089
C 1.41 0.94
Factor Group Mean SD
Have difficulty finding food dropped on the floor? IE 1.32 0.65 0.17 <0.001 0.03 <0.001
C 1.21 0.52
Progression question Factor Group Mean SD
Compared with six months ago, does
your dog?
Pace up and down, walk in circles and/or wander with no
direction or purpose?
IE 2.78 0.88 -0.05 0.258 0.02 <0.001
C 2.86 0.64
Stare blankly at the walls or floor? IE 2.74 0.93 -0.09 0.022 0.01 0.002
C 2.85 0.62
Urinate or defecate in an area it has previously kept clean? IE 2.64 0.94 -0.10 0.028 0.02 <0.001
C 2.89 6.86
Have difficulty finding food dropped on the floor? IE 5.35 1.73 -0.17 <0.001 0.01 <0.001
C 5.74 1.22
Fail to recognise familiar people or pets? IE 7.90 2.60 -0.20 <0.001 0.003 0.316
C 8.52 1.78
Factor Group Mean SD
Is the amount of time your dog spends active? IE 3.31 0.89 0.27 <0.001 0.07 <0.001
C 3.17 0.73
https://doi.org/10.1371/journal.pone.0192182.t007
Table 8. Univariate associations between epilepsy phenotype and canine cognitive dysfunction (CCD) score in the sub-group of dogs with IE.
Variable Category N CCDR Score B 95% CI p
Age at first seizure - 269 - 0.01 -0.05–0.06 0.767
Duration of epilepsy - 269 - -0.02 -0.05–0.01 0.248
Seizure frequency - 276 - 0.547 0.170–0.925 0.005
Cluster seizures No clusters 65 32.18 ± 1.04 -3.81 -6.23 - -1.40 0.002
Clusters 216 36.00 ± 8.74 -
Status epilepticus No 197 34.41 ± 8.26 -2.41 -4.73 - -0.09 0.042
Yes 77 36.82 ± 9.98 -
https://doi.org/10.1371/journal.pone.0192182.t008
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difference in the frequency of these behaviours compared to control dogs. Alterations in social
interactions have been considered a core sign of CCD [44], thus adding to the argument that
cognitive impairment in IE differs in aetiology from that of geriatric-onset CCD
With the exception of the amount of time spent physically active, dogs with IE did not
show greater ‘progression’ of CCD signs than controls. Indeed, control dogs showed signifi-
cantly worse impairment in four of the five progression elements of the CCDR, which compare
behaviour to six months previously. Progressive deterioration in CCD signs in control dogs
likely reflects the cognitive ageing process, with cognitive and neurobiological changes
observed in dogs entering middle age, and becoming more pronounced as they become geriat-
ric [45]. In contrast, the lack of progression in dogs with IE may reflect their cognitive
impairment progressing at an earlier stage than when owners were surveyed, and thus CCD
signs have stabilised at the point of this cross-sectional study. Longitudinal study of dogs with
IE from age at onset are required to explore this effect further.
Age of onset of cognitive impairment in canine epilepsy
In addition to the static nature of cognitive compromise in dogs with IE, a significant interac-
tion between epilepsy and age was identified, such that dogs with IE exhibited significantly
Table 9. Univariate associations between anti-epileptic drug treatment and canine cognitive dysfunction (CCD) score (from 16–80) in the sub-group of dogs
(n = 286) with epilepsy. SF = Seizure frequency.
Variable Category N CCDR Score B 95% CI p
Number of AEDs None 32 34.41 ± 6.85 Reference
1 128 34.46 ± 8.26 0.06 -3.38–3.49 0.975
2 38 34.92 ± 10.71 0.51 -3.12–4.13 0.782
3 37 37.73 ± 8.08 3.32 -0.87–7.52 0.120
4 6 36. 33 ± 2.07 1.93 -5.80–9.66 0.624
Imepitoin Yes 45 34.65 ± 9.67 -0.96 -3.78–1.87 0.507
No 241 35.20 ± 86.65 Reference
Phenobarbital Yes 181 35.56 ± 9.34 1.39 -0.74–3.52 0.201
No 105 34.34 ± 7.71 Reference
Potassium Bromide No 87 35.59 ± 8.40 0.77 -1.47–3.01 0.497
Yes 199 34.91 ± 8.97 Reference
Levetiracetam Yes 74 36.82 ± 9.29 2.40 0.06–4.73 0.044
No 212 34.51 ± 8.55 Reference
AED response Increased SF 21 37.71 ± 9.12 4.49 0.12–8.86 0.044
<50% reduction SF 10 38.90 ± 7.25 5.67 -0.17–11.52 0.057
No change SF 57 34.86 ± 8.12 1.63 -1.60–4.87 0.321
>50% reduction SF 101 35.39 ± 8.96 2.16 -0.72–5.04 0.140
Seizure free 53 33.23 ± 8.45 Reference
https://doi.org/10.1371/journal.pone.0192182.t009
Table 10. Generalised linear model of risk factors for CCDR score in the sub-population of dogs with epilepsy (n = 286).
Variable Category N Estimate SE t p
Intercept - - 31.54 1.09 29.97 <0.001
Seizure frequency - 276 1.14 0.39 2.90 0.004
Seizure frequency ^ 2 (quadratic) - 276 -0.03 0.02 -2.02 0.044
Cluster seizures No clusters 65 2.74 1.27 2.16 0.032
Clusters 216 Reference
https://doi.org/10.1371/journal.pone.0192182.t010
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higher CCDR scores at a young age (<4 years). This is in contrast with control dogs, for whom
CCD risk remained extremely low while young-middle aged, and did not elevate until dogs
were in the geriatric phase (>10 years), the age at which CCD is most commonly diagnosed.
These findings may point towards an initial insult to cognitive function associated with epi-
lepsy, rather than a progressive cognitive deterioration as classically seen in CCD in dogs and
dementia in humans. Further data are required to characterise cognitive ageing associated
with canine epilepsy. The lower limit for a diagnosis of IE is generally considered to be six
months [38], but may be as high as six years. As this study focused on adult dogs, those<3
years of age were not included. Future studies that assess cognition from the onset of epilepsy
will help to characterise initial deficits.
Although from the current statistical models CCD risk reduces with age in dogs with IE,
there was a paucity of CCDR data for dogs with epilepsy aged >10 years old. The low numbers
in this sub-population limit our interpretation of the statistical models that compare geriatric
dogs with epilepsy vs. controls in the age bracket for which CCD prevalence peaks in the con-
trol population. The relative shortage of dogs in this age group may well reflect the reduced
longevity of dogs with epilepsy. The median longevity in a study of 102,609 dogs attending UK
first opinion veterinary practices was 12.0 years (interquartile range: 8.9–14.2) [46]. In con-
trast, in longevity studies of canine epilepsy populations, the estimated median age at death
was markedly lower, estimated at 7 years of age in two separate studies (median: 7.0, interquar-
tile range: 3.0–10.0; [47]; median: 7.0, interquartile range: 3.0–11.0; [48]). Indeed, the median
survival time after the first seizure has been estimated to range from only 2.07 years [49] to 2.3
years [48]. Several factors predict reduced survival time in dogs with epilepsy, including poor
seizure control and a high initial seizure frequency [50]. As increased seizure frequency was
associated with higher CCDR score in the epilepsy sub-population, it is possible that the preva-
lence of CCD in that population may be underestimated, if those dogs were at an elevated risk
of premature death and thus censored from this study.
Epilepsy-induced impairment vs. canine dementia
The current data demonstrate similarities in some elements of cognitive impairment in dogs
with IE and dogs with geriatric-onset cognitive dysfunction, for example, memory function is
impaired in both. However, the progression and age of onset of cognitive dysfunction observed
in the IE population appears to diverge from that seen in CCD, which likely points to divergent
aetiology. Rather than the pathophysiological mechanisms underlying age-related brain
changes and dementia, it is possible that epilepsy interferes with the development of the canine
brain networks which underlie cognition [16]. This aetiology may simultaneously contribute
to the generation of seizures and to lasting changes in neural circuitry that compromise the
canine brains’ ability to process and store information, reflected in memory impairments.
These impairments may result from temporary disruption of neural activity patterns, and
become permanent if seizures are more frequent [42]. As seen within the current IE sub-popu-
lation (n = 286), an elevated risk of cognitive dysfunction was observed in those dogs with the
most seizure activity (cluster seizure activity and higher seizure frequencies). Seizure frequency
has been associated with the degree of mental decline in humans [51], and memory is consid-
ered the cognitive function most vulnerable to seizures [52]. From the current cross-sectional
data, it remains unclear whether this effect in dogs is a reflection of (i) an underlying epilepsy
phenotype characterised by degenerative cerebral processes that give rise to cognitive im-
pairment and high seizure frequency, or (ii) progressive damage from recurrent seizures. Lon-
gitudinal studies, including cognitive testing combined with neuroimaging (e.g. hippocampal
volume), could provide evidence to test either hypothesis.
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Impact of anti-epileptic drug treatment
In the current multivariate analysis, there was no effect of AED treatment on CCDR score,
which is surprising given that AEDs are a major contributor to cognitive impairment in people
with epilepsy [53]. This finding should be taken with caution, as 88% of the epilepsy popula-
tion studied was being treated with AEDs, and thus the control population was of only limited
size. AED-induced adverse cognitive and psychotropic effects are thought to reflect suppres-
sion of neuronal excitability or enhancing inhibitory neurotransmission, but the actual neuro-
biological mechanisms of AED-induced cognitive dysfunction are poorly understood [54]. To
date, the potential cognitive side-effects of AEDs have been largely neglected in veterinary sci-
ence, and thus few data on these effects exist.
Risk factors for CCD
The current study identified age as a major predictor of CCD risk, as has been reported in pre-
vious studies [31–33]. In control dogs, CCD prevalence was observed to increase with age, as
has been previously documented, with peak prevalence observed in dogs aged>14 years old in
both this study and a previous cross-sectional study [33]. Lighter dogs were found to be at an
increased risk of CCD in this study, when accounting for age. In a previous study, small dogs
(<15kg) had a significantly greater prevalence of CCD than medium-large dogs (>15kg) [32].
In contrast, two previous studies did not find an effect of size on CCD risk, when measured by
height at the withers [33] and body weight [31]. This finding may be unexpected, as it is well
established that larger dogs size die at a younger age [55], which is presumed to be as a func-
tion of more rapid aging of the body. This hypothesis would predict the opposite findings, that
larger dogs have an increased risk of CCD than small dogs [56]. However, no studies to date
have identified this effect, and from these findings it appears that processes in the brain
responsible for age-related behavioural changes may progress more rapidly in smaller dogs.
Finally, dogs with a higher training history score were found to be at lower risk of CCD,
which may indicate neuroprotective effects of life experiences that enhance cognition. Higher
levels of training have been found to enhance peformance in dogs in various problem-solving
tasks [57–59]. Previous studies have found that lifelong training can have protective effects on
cognitive function in dogs, for example, increased levels of lifelong training seem to delay or
reduce the aging of attentiveness, a cognitive function that declines with age [60]. The possibil-
ity of a connection between life experience and the prevalence of dementia has long been dis-
cussed in human medicine, with the concept of “cognitive reserve” (CR) increasingly being
investigated to account for individual differences in susceptibility to dementia or AD-related
pathology [61]. The concept of reserve accounts for individual differences in susceptibility to
age-related brain changes or Alzheimer’s disease-related pathology. There is evidence that
some people can tolerate more of these changes than others and still maintain function. Epide-
miologic studies suggest that lifetime exposures including educational and occupational attain-
ment, and leisure activities in late life, can increase this reserve. For example, there is a reduced
risk of developing Alzheimer’s disease in individuals with higher educational or occupational
attainment. It is convenient to think of two types of reserve: brain reserve, which refers to
actual differences in the brain itself that may increase tolerance of pathology, and cognitive
reserve. Cognitive reserve refers to individual differences in how tasks are performed that may
allow some people to be more resilient than others. The concept of cognitive reserve holds out
the promise of interventions that could slow cognitive aging or reduce the risk of dementia.
Epidemiological studies suggest that lifetime exposures including educational and occupa-
tional attainment [62], and leisure activities in later life [63], can increase this reserve, resulting
in a reduced risk of developing dementia or AD. Based on the results of 22 cohort studies that
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examined the effects of education, occupation, premorbid IQ and mental activities on demen-
tia risk, higher CR decreases the risk of developing dementia by 46% [64]. The reduced lifespan
of dogs in comparison to humans may allow for prospective intervention studies to initially
confirm this effect, and to further identify which activities e.g. obedience or agility training,
may protect against CCD in later life.
Conclusions
This study provides initial evidence of increased levels of cognitive dysfunction in dogs with
idiopathic epilepsy. Although a screening tool for CCD (‘canine dementia’) was used to quan-
tify cognitive abnormalities, the age of onset, nature and progression of cognitive impairment
in dogs with epilepsy appears divergent from those seen in CCD. Other pathological processes
are likely to underlie these abnormalities. Further longitudinal studies measuring cognition
from the time of seizure onset are required to further characterise the progression of cognitive
dysfunction in this population, with additional data (where possible) required from geriatric
dogs with epilepsy to explore the interplay between epilepsy-induced cognitive impairment,
and impairments related to normal ageing and CCD. In addition, clinicopathological studies
are needed in dogs with IE to determine if, like in human epilepsy, they also express higher lev-
els of Alzheimer pathology than normal. This study also identified age, size and training his-
tory as risk factors for CCD. Positive effects of training experiences should be further explored
in the canine population, to identify whether, as in humans, they can increase cognitive reserve
and protect against CCD.
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